Precision Therapy for Invasive Fungal Diseases

por Märtson, Anne-Grete, Alffenaar, Jan-Willem C., Brüggemann, Roger J., Hope, William
Publicado 2021

Optimizing Antimicrobial and Host-Directed Therapies to Improve Clinical Outcomes of Childhood Tuberculous Meningitis( )

por Gafar, Fajri, Marais, Ben J, Nataprawira, Heda M, Alffenaar, Jan Willem C
Publicado 2021

Relevance of the drug–drug interactions between lidocaine and the pharmacokinetic enhancers ritonavir and cobicistat

por Dekkers, Bart G.J., Bierman, Wouter F.W., Touw, Daan J., Alffenaar, Jan-Willem C.
Publicado 2019

Treatment outcomes of drug-resistant tuberculosis in the Netherlands, 2005–2015

por Pradipta, Ivan S., van’t Boveneind-Vrubleuskaya, Natasha, Akkerman, Onno W., Alffenaar, Jan-Willem C., Hak, Eelko
Publicado 2019

Interventions to improve medication adherence in tuberculosis patients: a systematic review of randomized controlled studies

por Pradipta, Ivan S., Houtsma, Daphne, van Boven, Job F. M., Alffenaar, Jan-Willem C., Hak, Eelko
Publicado 2020

Pharmacokinetic Drug Interactions of Antimicrobial Drugs: A Systematic Review on Oxazolidinones, Rifamycines, Macrolides, Fluoroquinolones, and Beta-Lactams

por Bolhuis, Mathieu S., Panday, Prashant N., Pranger, Arianna D., Kosterink, Jos G. W., Alffenaar, Jan-Willem C.
Publicado 2011

In vitro evaluation of an intravenous microdialysis catheter for therapeutic drug monitoring of gentamicin and vancomycin

por van der Mast, Jackelien E., Nijsten, Maarten W., Alffenaar, Jan‐Willem C., Touw, Daan J., Bult, Wouter
Publicado 2019

Barriers and strategies to successful tuberculosis treatment in a high-burden tuberculosis setting: a qualitative study from the patient’s perspective

por Pradipta, Ivan S., Idrus, Lusiana R., Probandari, Ari, Lestari, Bony W., Diantini, Ajeng, Alffenaar, Jan-Willem C., Hak, Eelko
Publicado 2021

Barriers to Optimal Tuberculosis Treatment Services at Community Health Centers: A Qualitative Study From a High Prevalent Tuberculosis Country

por Pradipta, Ivan S., Idrus, Lusiana R., Probandari, Ari, Puspitasari, Irma Melyani, Santoso, Prayudi, Alffenaar, Jan-Willem C., Hak, Eelko
Publicado 2022

Diabetes mellitus comorbidity in patients enrolled in tuberculosis drug efficacy trials around the world: A systematic review

por Lutfiana, Nurul Cholifah, van Boven, Job F.M., Masoom Zubair, Muhammad Asim, Pena, Michelle J., Alffenaar, Jan‐Willem C.
Publicado 2019

Respiratory Syncytial Virus Infection Morbidity in the Elderly: Time for Repurposing of Ribavirin?

por de Zwart, Auke E S, Riezebos-Brilman, Annelies, Kerstjens, Huib A M, Verschuuren, Erik A M, Alffenaar, Jan-Willem C
Publicado 2020

Standard ganciclovir dosing results in slow decline of cytomegalovirus viral loads

por Märtson, Anne-Grete, Sturkenboom, Marieke G. G., Knoester, Marjolein, van der Werf, Tjip S., Alffenaar, Jan-Willem C., Hope, William
Publicado 2021

Correction to: A Model-Informed Method for the Purpose of Precision Dosing of Isoniazid in Pulmonary Tuberculosis

por van Beek, Stijn W., ter Heine, Rob, Alffenaar, Jan-Willem C., Magis-Escurra, Cecile, Aarnoutse, Rob E., Svensson, Elin M.
Publicado 2021

A Model-Informed Method for the Purpose of Precision Dosing of Isoniazid in Pulmonary Tuberculosis

por van Beek, Stijn W., ter Heine, Rob, Alffenaar, Jan-Willem C., Magis-Escurra, Cecile, Aarnoutse, Rob E., Svensson, Elin M.
Publicado 2021

Pharmacokinetics and pharmacodynamics of anti-tuberculosis drugs: An evaluation of in vitro, in vivo methodologies and human studies

por Alffenaar, Jan-Willem C., de Steenwinkel, Jurriaan E. M., Diacon, Andreas H., Simonsson, Ulrika S. H., Srivastava, Shashikant, Wicha, Sebastian G.
Publicado 2022

Predictors of Prolonged TB Treatment in a Dutch Outpatient Setting

por van’t Boveneind-Vrubleuskaya, Natasha, Daskapan, Alper, Kosterink, Jos G. W., van der Werf, Tjip S., van den Hof, Susan, Alffenaar, Jan-Willem C.
Publicado 2016

A mobile microvolume UV/visible light spectrophotometer for the measurement of levofloxacin in saliva

por Alffenaar, Jan-Willem C, Jongedijk, Erwin M, van Winkel, Claudia A J, Sariko, Margaretha, Heysell, Scott K, Mpagama, Stellah, Touw, Daan J
Publicado 2020

Therapeutic Drug Monitoring of Ganciclovir: Where Are We?

por Märtson, Anne-Grete, Edwina, Angela E., Kim, Hannah Yejin, Knoester, Marjolein, Touw, Daan J., Sturkenboom, Marieke G. G., Alffenaar, Jan-Willem C.
Publicado 2022

Risk factors contributing to a low darunavir plasma concentration

por Daskapan, Alper, Stienstra, Ymkje, Kosterink, Jos G. W., Bierman, Wouter F. W., van der Werf, Tjip S., Touw, Daan J., Alffenaar, Jan‐Willem C.
Publicado 2017

Ganciclovir Therapeutic Drug Monitoring: A Case Series

por Märtson, Anne-Grete, Touw, Daan, Damman, Kevin, Bakker, Martijn, Oude Lansink-Hartgring, Annemieke, van der Werf, Tjip, Knoester, Marjolein, Alffenaar, Jan-Willem C.
Publicado 2019